The urea breath test market comprises urea breath testing kits that are used to detect the presence of Helicobacter pylori infection in the stomach and duodenum. Urea breath tests are a non-invasive way to diagnose and monitor eradication of H. pylori infection. It relies on the ability of H. pylori to break down urea into carbon dioxide and ammonia. The increasing global prevalence of H. pylori infections primarily drives the demand for urea breath tests.

The global urea breath test market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period of 2024 to 2030.

Key Takeaways

Key players operating in the Urea Breath Test Market Share are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company.

The rising awareness regarding H. pylori infections and their health implications present significant growth opportunities for players in the urea breath test market. Furthermore, innovations leading to the development of more accurate, convenient and affordable testing kits are expected to boost demand.

Globally, players are focused on expanding into emerging markets of Asia Pacific, Latin America, and Middle East & Africa seeing increasing healthcare expenditures and lack of widespread diagnostic capabilities for H. pylori in these regions.

Market Drivers

Increasing prevalence of H. pylori infections driven by lack of sanitation and crowded living conditions in developing nations is a major factor driving the demand for urea breath tests. According to WHO, over 50% of the world's population is infected with H. pylori, making it one of the most common bacterial infections worldwide.

Moreover, rising awareness about H. pylori infections as a risk factor for gastric cancer and ulcers is prompting more physicians to recommend confirmatory testing, thereby supporting the urea breath test market growth. However, the market faces challenges in terms of lack of reimbursement for H. pylori diagnostic tests in several countries.

Segment Analysis

The urea breath test market is dominantly segmented based on technology which includes enzyme assay systems and analyzers. The analyzers segment currently dominates the market and is expected to continue its dominance during the forecast period. This is because analyzers offer automatic and faster detection of urease enzyme through mass spectrometry technique reducing manual errors. They provide precise quantification of urea levels in exhaled breath.

Within the analyzers segment, the mass spectrometry analyzers sub-segment accounts for the largest market share owing to features such as high sensitivity, selectivity and ability to detect low concentration of urea. Mass spectrometry technique also offers rapid analysis and eliminates the need for additional isotope enrichment steps.

Global Analysis

Regionally, North America accounts for the largest share in the urea breath test market currently. This is attributed to high awareness regarding diagnosis of helicobacter pylori infection, availability of advanced healthcare facilities along with reimbursement policies and presence of key players in the region. Europe is the second largest regional market fueled by increasing healthcare expenditure.

Asia Pacific is anticipated to exhibit fastest growth during the forecast period owing to rising geriatric population, improving healthcare infrastructure and changing lifestyle leading to increased helicobacter pylori infection rates in the region. Emerging countries like China and India are expected to offer lucrative opportunities for players.

Get more insights on Urea Breath Test Market